Aggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib

Actas Dermosifiliogr (Engl Ed). 2019 Dec;110(10):863-865. doi: 10.1016/j.ad.2018.05.022. Epub 2019 Sep 9.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Anilides / therapeutic use*
  • Carcinoma, Basal Cell / drug therapy*
  • Carcinoma, Basal Cell / pathology
  • Eyelid Neoplasms / drug therapy*
  • Eyelid Neoplasms / pathology
  • Humans
  • Male
  • Neoadjuvant Therapy
  • Pyridines / therapeutic use*

Substances

  • Anilides
  • HhAntag691
  • Pyridines